The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fuel cell catalyst scale-up agreement

16 Jun 2010 07:00

RNS Number : 6788N
Ilika plc
16 June 2010
 



Ilika plc

 

("Ilika" or the "Company")

 

 

Fuel cell catalyst scale-up agreement

 

 

Ilika and ITRI to scale up and commercialise next generation fuel cell catalysts

 

 

Ilika plc (AIM:IKA), the advanced cleantech materials discovery company, has signed an agreement with Taiwan's premier not-for-profit R&D organisation, the Industrial Technology Research Institute ("ITRI"), to scale-up and commercialise jointly the next generation fuel cell catalysts. The Company believes this agreement will be a vital component of the energy industry's efforts to develop consumer-friendly fuel cell technology.

 

Since initially developing and patenting a lower cost, platinum-free fuel cell catalyst in 2006, Ilika has undertaken further development of the compound and is now confident that it offers cost and availability benefits relative to competing technology.

 

ITRI possesses state-of-the-art integrated abilities in fuel cell technology, including material and device development, manufacturing, application and evaluation, and has agreed to enter into a non-exclusive collaboration to scale-up Ilika's catalyst materials.

 

Under this agreement the parties aim to have samples available to potential customers in approximately 18 months. ITRI will meet the cost of this scale-up work. Thereafter catalyst material should be available for large scale supply during the following 12 months.

 

The parties have also agreed to co-operate in the commercialisation and marketing of the new catalyst, taking full advantage of their global network of potential users.

 

Ilika's Chief Executive, Graeme Purdy, said, "This agreement is a great example of how Ilika develops innovative materials that solve complex industrial challenges together with our partners and shares in the commercial upside that these technological advances make possible.

 

ITRI is a world leader with renowned capability in the field of fuel cell catalysts. We are very pleased it has agreed to enter into this agreement."

 

The global market for fuel cells is growing rapidly, with sales in Europe alone expected to grow to €3.6 billion by 2016. Catalysts make up about 40% of the cost of a typical fuel cell.

 

Dr. Jonq Ming Liu, Vice president and General Director Of Material and Chemical Research Labs, ITRI, concluded, "ITRI hopes to establish more opportunities for international cooperation and technology transfer, and we are delighted to have this opportunity to work with Ilika."

 

 

- Ends -

 

 

For more information contact:

 

Ilika plc

Graeme Purdy, Chief Executive

Steve Boydell, Finance Director

+44 (0) 23 80111400

 

Nomura Code Securities Limited

Phil Walker / Christopher Golden

+44 (0) 20 7776 1200

Pelham Bell Pottinger

Archie Berens/ Olly Scott / Francesca Tuckett

+44 (0) 20 7861 3232

 

 

 

About Ilika

 

Ilika (AIM: IKA) is an advanced materials company which accelerates the discovery of new and patentable materials using its unique high throughput technologies (''HTT'') process for identified end uses in the energy, electronics and biomedical sectors. This process enables hundreds of scalable materials to be made in a single, automated operation and subsequently tested for key properties.

 

Traditionally, materials development has been a slow and arduous task, with manual, sequential methods used to make samples of material that are then tested for suitability. On average, it takes between 7 and 10 years to move from an initial discovery through to the first commercial prototype. Experiments carried out by the Company can be executed 10 to 100 times faster than using traditional techniques.

 

The Company focuses on three principal sectors and has a number of active development programmes addressing markets within each sector:

 

Energy - developing innovative new materials for Lithium-ion batteries for vehicles for Toyota; developing high capacity hydrogen storage materials with Shell Hydrogen and Johnson Matthey through joint development programmes; developing cheaper alternatives to Platinum electrodes for use in fuel cells through a grant-funded project with the Carbon Trust; developing new materials for use in fuel cells for the transport sector for a major vehicle manufacturer; and carrying out in-house research on film photovoltaic solar cells.

 

Electronics - developing lead-free piezoelectric materials through a joint development programme with CeramTec; and developing phase change memory materials for high capacity memory.

 

Biomedical - developing polymers to enable the filtering of somatic stem cells from blood with a major global supplier of filters; it has been selling its Cryoskin and Myskin products for the treatment of burns and wounds in the UK through a specialist distributor and intends to commence clinical trials of its corneal bandage candidate.

 

The Group's commercialisation strategy is to enter into joint development or licensing agreements with large multinational companies which are seeking to commercialise products developed using the intellectual property created through jointly-funded programmes. Current commercialisation partners include large multinational companies such as Toyota, Shell, Johnson Matthey and CeramTec. The Company generates revenues from three sources: licensing and milestone payments from joint development programmes; fee for service from contract research projects; and from sales of Cryoskin and Myskin.

 

www.ilika.com

 

About ITRI

 

The Industrial Technology Research Institute (ITRI) is a not-for-profit R&D organization engaging in applied research and technical services. Founded in 1973, ITRI has played a vital role in transforming Taiwan's economy from a labor-intensive industry to a high-tech industry. Numerous well-known high-tech companies in Taiwan, such as leaders in the semiconductor industry TSMC and UMC, can trace their origins to ITRI.

 

Innovative Research

ITRI is a multidisciplinary research center, with six core laboratories, five focus centers, five linkage centers, several leading labs and various business development units. The six fields ITRI focuses on include Information and Communication; Electronics and Optoelectronics; Material, Chemical and Nanotechnologies; Biomedical Technologies; Advanced Manufacturing and Systems; and Energy and Environment. ITRI has aggressively researched and developed countless next-generation technologies, including WIMAX wireless broadband, solar cells, RFID, light electric vehicles, flexible displays, 3-D ICs and telecare technologies. In addition, ITRI's Flexible Electronics Pilot Lab and Nanotechnology Lab provide international-level research platforms where R&D can be conducted jointly with partners. ITRI has also seen significant growth in intellectual property business and new ventures in recent years and is devoted to creating a model that would make Taiwan manufacturing even more competitive in the international arena.

Fostering Entrepreneurship and CEO Leadership

ITRI employs 5,800personnel, including 1,112 who hold Ph.D.s and 3,206with master's degrees, resulting in an average of five patents produced every day. By disseminating both technology and talent, ITRI has led the technology industry into the 21st century and has cultivated 70 CEOs in the local high-tech industry. In addition to its headquarters in Taiwan, ITRI has branch offices in the California Silicon Valley, Tokyo, Berlin and Moscow.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBLGDLIUBBGGU
Date   Source Headline
28th Oct 20137:00 amRNSIlika expands into Aerospace Sector
21st Oct 20137:00 amRNSInvestor Teach-in
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.